Related Experiment Video
Updated: Dec 9, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
SH3P2 suppresses osteoclast differentiation through restricting membrane localization of myosin 1E
Shota Nakamura1, Ritsuko Masuyama2, Kosuke Sakai1
1Department of Cell Regulation, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Abstract:
Osteoclasts are multinucleated cells responsible for bone resorption. Src homology 3 (SH3) domain-containing protein-2 (SH3P2)/osteoclast-stimulating factor-1 regulates osteoclast differentiation, but its exact role remains elusive. Here, we show that SH3P2 suppresses osteoclast differentiation. SH3P2 knockout (KO) mice displayed decreased femoral trabecular bone mass and enhanced localization of osteoclasts on the tibial trabecular bone surface, suggesting that SH3P2 suppresses bone resorption by osteoclasts. Osteoclast differentiation based on cellular multinuclearity induced by macrophage colony-stimulating factor and receptor activator of nuclear factor-κB ligand (RANKL) was enhanced in bone marrow-derived macrophages lacking SH3P2. RANKL induced SH3P2 dephosphorylation, which increased the association of actin-dependent motor protein myosin 1E (Myo1E) with SH3P2 and thereby prevented Myo1E localization to the plasma membrane. Consistent with this, Myo1E in the membrane fraction increased in SH3P2-KO cells. Together with the attenuated osteoclast differentiation in Myo1E knocked down cells, SH3P2 may suppress osteoclast differentiation by preventing their cell-to-cell fusion depending on Myo1E membrane localization.
Insights
Src homology 3 (SH3) domain-containing protein-2 (SH3P2) suppresses osteoclast differentiation and bone resorption. SH3P2 knockout mice show reduced bone mass, indicating SH3P2
Area of Science:
- Bone Biology and Osteoclast Function
- Cellular Regulation of Bone Remodeling
Background:
- Osteoclasts are critical for bone resorption, and their differentiation is tightly regulated.
- The precise role of Src homology 3 (SH3) domain-containing protein-2 (SH3P2) in osteoclast biology was previously unclear.
Purpose of the Study:
- To elucidate the function of SH3P2 in osteoclast differentiation and bone resorption.
- To investigate the molecular mechanisms by which SH3P2 influences osteoclast formation.
Main Methods:
- Utilized SH3P2 knockout (KO) mice to assess bone mass and osteoclast localization.
- Examined osteoclast differentiation in vitro using bone marrow-derived macrophages stimulated with macrophage colony-stimulating factor and receptor activator of nuclear factor-κB ligand (RANKL).
- Investigated the interaction between SH3P2 and myosin 1E (Myo1E) following RANKL stimulation.
Main Results:
- SH3P2 KO mice exhibited decreased femoral trabecular bone mass and increased osteoclast presence on tibial bone.
- Osteoclast differentiation was enhanced in macrophages lacking SH3P2.
- RANKL-induced SH3P2 dephosphorylation promoted Myo1E association with SH3P2, hindering Myo1E's plasma membrane localization.
Conclusions:
- SH3P2 acts as a suppressor of osteoclast differentiation and bone resorption.
- SH3P2 regulates osteoclast formation by modulating the localization of the actin-dependent motor protein Myo1E.
- These findings reveal a novel mechanism by which SH3P2 controls cell-to-cell fusion during osteoclastogenesis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hedgehog Signaling Pathway

